ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Rhinopront®:Pfizer AG
Complete information for professionalsDDDPrint 
Galenic Form / Therapeutic GroupComposition.EffectsPharm.kinetikIndication.UsageRestrictions.Unwanted effects
Interactions.OverdoseOther adviceSwissmedic-Nr.Last update of information 

Zusammensetzung

Kapseln

1 Kapsel enthält:

Wirkstoffe: Carbinoxamini hydrogenomaleas 4 mg, Phenylephrini hydrochloridum 20 mg.

Hilfsstoffe: Saccharum, Maydis amylum, Eudragit RS 100, Diethylis phthalas, Oleum neutrale, Talcum, Color: E 132 (Indigotin I), E 172, E 171 (Titanii dioxidum), Gelatina.

Saft

5 ml Saft enthalten:

Wirkstoffe: Phenylpropanolaminum 16,7 mg ad resinam adsorbatum, Carbinoxaminum 1,3 mg ad resinam adsorbatum.

Hilfsstoffe: Natrii chloridum, Natrii maleas, Natrii edetas, Saccharinum natricum, Hydrogel 843 T, Conserv.: E 218 (Methylis parahydroxybenzoas), E 216 (Propylis parahydroxybenzoas), Sorbitolum 70 per centum, Natrii citras, Aroma caramelli, Color E 110, Aqua purificata.

2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home